Spotify stock slips: piracy injunction and fresh target cuts put SPOT back in focus
21 January 2026
1 min read

Spotify stock slips: piracy injunction and fresh target cuts put SPOT back in focus

New York, Jan 21, 2026, 14:06 EST — Regular session

  • Spotify shares dipped roughly 2.3% in midday trading on the NYSE
  • Barclays cuts its SPOT price target to $625 from $700 but maintains an Overweight rating
  • A U.S. court has issued a preliminary injunction concerning alleged scraping activities and upcoming torrent releases connected to Anna’s Archive

Spotify Technology S.A. shares slipped $11.53, roughly 2.3%, settling at $499.80 by mid-afternoon Wednesday. The stock started the day close to $512 and dipped to a low near $496. Over the last 52 weeks, the price has swung between $240.49 and $625.00.

This matters as investors face a packed slate of catalysts: the next earnings report is looming, and the stock is suddenly swarming with legal news and analyst talk. For a name priced on execution, it won’t take much to unsettle it.

Wall Street’s tone has grown pickier as 2026 gets underway, with rapid shifts in target prices signaling that momentum isn’t just about upgrades. For Spotify, the focus is on whether pricing power and cost control can meet the high bar set by investors.

Barclays analyst Kannan Venkateshwar maintained an “Overweight” rating on Spotify but trimmed his price target to $625 from $700, a report out Tuesday shows. Other firms have similarly lowered their targets recently, though most remain bullish on the stock. 1

On the legal front, a preliminary injunction — a court order that can halt a defendant’s activities during litigation — was issued in a copyright case involving Spotify and major record labels against “Anna’s Archive,” a U.S. court filing dated Jan. 20 shows. The order instructs domain registries and service providers to block access to multiple Anna’s Archive domains and to preserve evidence that might reveal the operators behind them. 2

The complaint defines “scraping” as the unauthorized copying of massive amounts of data. It accuses Anna’s Archive of taking metadata for roughly 256 million audio tracks and 86 million music files from Spotify without permission. According to the filing, Anna’s Archive asserted that these files accounted for 99.6% of Spotify “listens,” and warned of large-scale releases through BitTorrent, a peer-to-peer network commonly linked to piracy.

Spotify has turned to pricing adjustments. Last week, it announced a $1 hike in its U.S. Premium plan, pushing the monthly fee to $12.99. The company is applying similar increases in several other countries. 3

This shifts focus onto churn—the danger users will quit—and how far Spotify can raise prices before ceding ground to competitors like Apple and Amazon.

The situation could shift. A strained consumer environment might undercut the ability to maintain price hikes, and legal moves against piracy rings often drag on, with unclear effects on actual distribution.

All eyes turn to Feb. 10, when Spotify is set to release its Q4’25 earnings at 8:00 a.m. Eastern. The focus will be on subscriber numbers, ad sales momentum, and any news on the piracy lawsuit and enforcement moves. 4

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
CrowdStrike stock falls while the S&P rises — what CRWD investors are watching next
Previous Story

CrowdStrike stock falls while the S&P rises — what CRWD investors are watching next

Pfizer (PFE) stock edges up as ViiV exit cash and Novavax vaccine-tech pact grab attention
Next Story

Pfizer (PFE) stock edges up as ViiV exit cash and Novavax vaccine-tech pact grab attention

Go toTop